<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A method that allows the quantitative assessment of ileal mucosal cell uptake and transport of <z:chebi fb="1" ids="3098">bile acids</z:chebi> in mucosal biopsy specimens has been validated </plain></SENT>
<SENT sid="1" pm="."><plain>Viability of the tissue was confirmed by maintenance of <z:mpath ids='MPATH_458'>normal</z:mpath> cell <z:mp ids='MP_0000002'>morphology</z:mp>, wet weight, extracellular space, porosity to <z:chebi fb="1" ids="46793">polyethylene glycol</z:chebi>-900, <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase release, and transmucosal potential difference </plain></SENT>
<SENT sid="2" pm="."><plain>Using <z:chebi fb="32" ids="36927">14C</z:chebi>-<z:chebi fb="0" ids="28865">taurocholic acid</z:chebi>, absorption was shown to be directional, capable of working against a concentration gradient, reduced by metabolic inhibitors, and <z:chebi fb="199" ids="26708">sodium</z:chebi> dependent </plain></SENT>
<SENT sid="3" pm="."><plain>The system showed saturation kinetics with an estimated Km of 10 mumol/l </plain></SENT>
<SENT sid="4" pm="."><plain>At a standard substrate concentration of 10 mumol/l ileal mucosal <z:chebi fb="0" ids="3098">bile acid</z:chebi> absorption was compared in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (n = 6), <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (n = 10), and slow transit <z:hpo ids='HP_0002019'>constipation</z:hpo> (n = 8) </plain></SENT>
<SENT sid="5" pm="."><plain>There was no significant difference in tissue uptake or transport between the three groups </plain></SENT>
</text></document>